Leukemia 2008,22(5):1053–6.PubMedCrossRef
15. Ries C, Loher F, Zang C, Ismair MG, Petrides PE: Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Dibutyryl-cAMP mouse Cancer Res 1999,5(5):1115–24.PubMed 16. Kaneta Y, Kagami Y, Tsunoda T, Ohno R, Nakamura Y, Katagiri T: Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray. Int J Oncol 2003,23(3):681–91.PubMed 17. Sang-Oh Yoon, Sejeong Shin, Ho-Jae Lee: Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinosito 3 kinase/Akt dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 2006,5(11):344–349. 18. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Dasatinib concentration Aggarwal BB: Curcumin and cancer: an “”old-age”" disease with an “”age-old”" solution. Cancer Lett 2008,267(1):133–64.PubMedCrossRef 19. Fang Baijun, Zheng Chunmei, Liao Lianming, Shi Mingxia, Yang Shaoguang, Zhao RCH: VX-809 purchase Identification of Human Chronic Myelogenous Leukemia Progenitor Cells with Hemangioblastic Characteristics. Blood 2005,105(7):2733–40.PubMedCrossRef 20. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie
CM: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001, 98:2615–25.PubMedCrossRef 21. Guo H, Fang B, Zhao RC: Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cells. Exp Hematol 2003, 31:650–613.PubMedCrossRef 22. Yunbiao Lu, Larry M: Wahl. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKK/NF-κB pathway. J Leuk Bio 2005, 78:259–65.CrossRef 23. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB: Cell type-specific expression of the IκB kinases determines the significance of phosphati-dylinositol 3-kinase/Akt signaling to NF-κB activation. J Biol Chem
2004, 279:1615–1620.PubMedCrossRef 24. Palamà IE, Leporatti S, de Luca E, Di Renzo N, Maffia M, Gambacorti-Passerini C, Rinaldi R, Gigli G, Cingolani R, Coluccia AM: Imatinib-loaded polyelectrolyte microcapsules PFKL for sustained targeting of BCR-ABL+ leukemia stem cells. Nanomedicine (Lond) 2010,5(3):419–31.CrossRef 25. Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, Porter DL, Uberti JP, King RJ, Confer DL: Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008,14(9 Suppl):8–15. 9PubMedCrossRef 26. Martin MG, Dipersio JF, Uy GL: Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leuk Lymphoma 2008, 29:1–10. 27.